|
|
News Breaks | | | | January 9, 2013 | | 09:59 EDT |  | HOLX | Hologic gaps up, levels to watch
The shares are up over 4.7% at time of writing, which is actually below earlier highs from the open. At the current price of $21.81, resistance is at $22.04, and then at $23.21, the high of the day. Support is at $21.43. The company announced the results of a new study in Radiology, the Radiological Society of North America scientific journal, that found 3D mammography with 2D breast exam increased efficacy. | |
|
News For HOLX From The Last 14 Days Check below for free stories on HOLX the last two weeks. |
|
|
| May 23, 2013 | | 10:37 EDT |  | HOLX | Hologic 3D mammography technology reduces recall rates, aids detection
 Subscribe for More Information | | | May 22, 2013 | | 10:16 EDT |  | HOLX | Hologic management to meet with Lazard Capital
Group dinner to be held in Boston on May 29 hosted by Lazard Capital. | | | May 21, 2013 | | 08:17 EDT | | HOLX | Hologic receives FDA approval for low-dose 3D mammography solution
Hologic announced that the FDA approved the use of Hologic's new C-View 2D imaging software. C-View 2D images may now be used in place of the conventional 2D exposure previously required as part of a Hologic 3D mammography screening exam. | | | May 15, 2013 | | 14:02 EDT | | HOLX | Leerink's medical devices analyst holds a conference call
Medical Devices Analyst Newitter discusses Hologic's tomosynthesis (3D) technology on an Analyst/Industry conference call to be held on May 16 at 2:30 pm. | |
|
|
|
|
|
|
